Clinical Trial: Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Lung Non-Small Cell Carcinoma
Study Type: INTERVENTIONAL
Official Title: SiCARIO (Split Course Adaptive Radioimmunotherapy) for the Treatment of Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Using Biologically-Adaptive Radiotherapy - A Phase I/II Study
Brief Summary:
This phase I/II trial tests the safety and efficacy of split-course, adaptive radiation therapy in combination with pembrolizumab with or without chemotherapy for the treatment of patients with stage IV lung cancer who have a limited number of metastases.Radiation therapy is a standard cancer treatment that uses highly focused, high energy x-rays to kill cancer cells and shrink tumors.In this trial, radiation therapy will be given as a split-course, with each treatment coinciding with the initiation of a…
Read more